Last updated on January 2017

A Phase 4, Double-Blind, Randomized, Placebo-Controllled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB)


Brief description of study

A Phase 4, Double-Blind, Randomized, Placebo-Controllled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB)

Detailed Study Description

Receive Mirabegron (FDA approved) or Placebo (Sugar Pill) as treatment for Overactive Bladder (OAB)

Clinical Study Identifier: TX147190

Find a site near you

Start Over

Clinical Research of South Florida

370 Minorca Avenue Coral Gables, FL USA
  Connect »